Related content

Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer

By Kuramoto Tomomi   Inagaki Takeshi   Fujii Reona   Sasaki Yumiko   Nishizawa Satoshi   Nanpo Yoshihito   Matusmura Nagahide   Kohjimoto Yasuo   Hara Isao  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 890-897

Springer Publishing Company

Access to resources Recommend Favorite

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

By Steineck Gunnar   Glimelius Bengt  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1589-1592

Informa Healthcare

Access to resources Recommend Favorite

Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 303-307

Science Publishers

Access to resources Recommend Favorite

Novel strategies in the treatment of castration-resistant prostate cancer (Review)

By          

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1313-1320

Spandidos Publications

Access to resources Recommend Favorite

Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature

By Moul Judd W.   Dawson Nancy  

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite